Bayer AG BAYRY announced that the FDA has accepted the company’s supplemental new drug application (sNDA) seeking label ...

US FDA accepts and grants priority review status to Bayer’s sNDA for Kerendia in chronic kidney disease associated with type 1 diabetes: Berlin Friday, May 22, 2026, 10:00 Hrs [ ...

Implementing Early Detection in CRM Syndrome,’ the expert nephrologist explored the following questions: What role do ...

Due to UACR variability, repeat testing may be necessary for clinical monitoring of patients with type 2 diabetes. The urinary albumin-to-creatinine ratio (UACR) can vary widely within individuals ...

Early albuminuria reduction with finerenone (Kerendia) drove protection against chronic kidney disease (CKD) progression in people with type 2 diabetes, according to a post-hoc mediation analysis. At ...

Please provide your email address to receive an email when new articles are posted on . Reduction of albuminuria benefited patients with CKD, type 2 diabetes. Patients who had 30% or greater reduction ...

Please provide your email address to receive an email when new articles are posted on . UACR had stronger associations than UPCR for children with moderate to severe proteinuria and albuminuria. Both ...

Researchers have found a seasonal variation in urinary albumin-to-creatinine ratio (UACR) in Japanese patients with type 2 diabetes and early nephropathy, with the highest values in winter and the ...